Cardinal Health (CAH)

As of 30 September 2026, short interest in CAH is 7,369,236 shares, up 655,774 shares over the last month. Over the last 48 readings it ranged from 4,224,695 shares (31 December 2024) to 9,000,257 shares (15 June 2026). At the reported average volume of 2.2M shares a day that is 3.4 days to cover.

<iframe src="https://xoomar.com/embed/stocks/cah" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

As of 9 October 2026, the short share of CAH volume is 46.2%, down 16.7 points over the last five sessions. Over the last 30 readings it ranged from 36.0% (22 September 2026) to 62.9% (2 October 2026). The latest reading is 3.6 points below the 30-session average of 49.8%, on 396K shares reported.

As of 14 August 2026, the fails-to-deliver balance in CAH is 1,184 shares, up 1,182 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (4 May 2026) to 12,292 shares (9 March 2026). The latest reading sits at the bottom of that range.

Insiders at CAH reported 31 open-market sells worth $59.6M in the last 90 days and no open-market buys. Latest filing: Scherer Mary C. (Chief Accounting Officer) on 2026-08-19.

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

3 Form 144 notices on file for CAH worth $2.1M at the prices reported; 0 in the last 90 days worth $0. Latest: Michelle Greene filed on 2026-02-27 to sell 2,746 shares ($627K) from 2026-02-27.

6 holders report 5% or more of CAH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (17,635,857 shares), filed 2026-04-29 for an event on 2026-03-31.

8 of the 30 tracked managers held CAH at their latest 13F, $816.2M in total at quarter-end prices. AQR Capital Management is the largest at $411.6M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 3 cut.

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

In Q2 FY 2026 (quarter ended 2025-12-31) Cardinal Health reported revenue of $65.63B, up 18.8% from the same quarter a year earlier, and net income of $467.0M. In FY 2026 it generated $5.17B of operating cash flow and spent $1.36B on buybacks and $491.0M on dividends.

Quarterly, last 8 quarters

Fiscal years, with buybacks and dividends

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.

11 contract actions on file for CAH: $9.2M obligated in the last 90 days and $9.6M in the last 12 months across 1 awarding agency. The largest was $3.1M from the Department of Veterans Affairs on 2026-10-01 (radiopharmaceuticals). This covers the largest contract actions, not every award, and agencies report late.